BLOG: Are you spending too much or too little on marketing? Part 2

A detailed how-to guide on ophthalmic marketing could easily fill hundreds of Healio blogs. (Indeed, SLACK/OSN published my first book, which was dedicated to ophthalmic marketing, 27 years ago. Looking at how primitive this book is today is an indication of how fast the field has changed since I wrote it.) To get started, let’s look at some of the numbers that should guide your decisions. As a first step in assessing your situation, prepare a graph for the past 12 or more months of the number of month-by-month new (Read more...)

Valeant to acquire Bausch + Lomb for $8.7 billion

Valeant Pharmaceuticals has agreed to purchase Bausch + Lomb for $8.7 billion in cash, according to a joint news release from the companies.Under the agreement, Bausch + Lomb will keep its name and function as a division of Valeant, and Valeant’s ophthalmology holdings will be folded into the Bausch + Lomb division, the release said.